Brind.
  1. FDA granted pre-market approval for Zephyr Valve.

Pulmonx appointed Steve Williamson as CEO and expanded treatment centers for Zephyr Valve.

1 report, 1 independent Updated Jul 31
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Pulmonx appointed Steve Williamson as CEO and expanded treatment centers for Zephyr Valve.

Who's involved

What this event is mainly about
Steve WilliamsonPulmonx (United States)

Keep exploring

Part of

FDA granted pre-market approval for Zephyr Valve. All 2 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswirePulmonx Reports Second Quarter 2025 Financial Results REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minim